{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:14:06Z","timestamp":1788261246534,"version":"build-2803163510"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective observational cohort study in a cardiogeriatric unit to compare cardiological, geriatric, biological, and therapeutic profiles across LVEF phenotypes in very old adults hospitalised for heart failure (HF). All patients with HF and classifiable LVEF were included and categorised according to 2021 European Society of Cardiology (ESC) criteria as heart failure with reduced ejection fraction (HFrEF, \u226440%), heart failure with mildly reduced ejection fraction (HFmrEF, 41%\u201349%), and heart failure with preserved ejection fraction (HFpEF, \u226550%). The primary objective was to describe and compare cardiological, biological, geriatric, and therapeutic profiles across LVEF phenotypes. The comprehensive geriatric assessment (CGA)-derived geriatric indicator count was used as a descriptive measure of multidimensional geriatric burden, and not as a validated frailty instrument.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among 1,299 patients [median age 88.5 years (IQR 82.5\u201392.2)], HFpEF predominated (58.8%). Despite markedly different cardiological profiles, CGA-derived geriatric burden was similar across phenotypes: the study-defined geriatric indicator count was identical in all groups [median 2 (1\u20133);\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.915;\n                      <jats:italic>\u03b7<\/jats:italic>\n                      \u00b2=0.00014]. Iron deficiency affected 52.8% of patients, with no significant difference across phenotypes (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.782). Clinically significant anaemia with concomitant iron deficiency was more frequent in HFpEF than in HFrEF (16.1% vs. 9.5%;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.001), whereas clinically significant anaemia without iron deficiency was similar across groups (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.986). In HFrEF, 52.6% received \u22653\/4 guideline-directed therapeutic pillars (defined as ACEi\/ARB\/ARNi, beta-blocker, MRA, and SGLT2i). Overall ACEi\/ARB\/ARNi pillar coverage was 53.2% in HFrEF, but ARNi uptake and MRA prescription declined with increasing age, with ARNi uptake falling from 44% before age 85 to 21% after age 90.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>LVEF category remains central to pharmacological treatment selection but does not discriminate CGA-derived geriatric burden or iron deficiency burden in very old HF patients. These findings support systematic comprehensive geriatric assessment and iron status assessment regardless of LVEF phenotype, alongside phenotype-informed pharmacological optimisation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fcvm.2026.1942320","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T10:15:53Z","timestamp":1788257753000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["LVEF-based phenotyping in very old adults hospitalised for heart failure: cardiological discrimination, shared geriatric burden, and treatment gaps"],"prefix":"10.3389","volume":"13","author":[{"given":"R\u00e9mi","family":"Esser","sequence":"first","affiliation":[{"name":"Department of Cardiogeriatrics, H\u00f4pital La Porte Verte","place":["Versailles, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Balesdent","sequence":"additional","affiliation":[{"name":"Department of Cardiogeriatrics, H\u00f4pital La Porte Verte","place":["Versailles, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Corny","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, H\u00f4pital La Porte Verte","place":["Versailles, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Larbaneix","sequence":"additional","affiliation":[{"name":"Department of Cardiogeriatrics, H\u00f4pital La Porte Verte","place":["Versailles, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Mondragon","sequence":"additional","affiliation":[{"name":"Department of Cardiogeriatrics, H\u00f4pital La Porte Verte","place":["Versailles, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marl\u00e8ne","family":"Esteban","sequence":"additional","affiliation":[{"name":"Department of Cardiogeriatrics, H\u00f4pital La Porte Verte","place":["Versailles, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Farges","sequence":"additional","affiliation":[{"name":"Department of Cardiogeriatrics, H\u00f4pital La Porte Verte","place":["Versailles, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Harboun","sequence":"additional","affiliation":[{"name":"Department of Cardiogeriatrics, H\u00f4pital La Porte Verte","place":["Versailles, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Nisse Durgeat","sequence":"additional","affiliation":[{"name":"Medical Affairs, NP Medical","place":["Bordeaux, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Palermo","sequence":"additional","affiliation":[{"name":"Cardiology Department, Centre Cardiologique Marie Lannelongue","place":["Le Plessis Robinson, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Maurou","sequence":"additional","affiliation":[{"name":"Department of Cardiogeriatrics, H\u00f4pital La Porte Verte","place":["Versailles, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.15420\/cfr.2016:25:2","article-title":"Global public health burden of heart failure","volume":"3","author":"Savarese","year":"2017","journal-title":"Card Fail Rev"},{"key":"B2","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s11897-013-0155-7","article-title":"The emerging epidemic of heart failure with preserved ejection fraction","volume":"10","author":"Oktay","year":"2013","journal-title":"Curr Heart Fail Rep"},{"key":"B3","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"B4","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"key":"B6","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1093\/eurjhf\/hft028","article-title":"Heart failure in elderly patients: distinctive features and unresolved issues","volume":"15","author":"Lazzarini","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"B7","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1001\/jamacardio.2016.1161","article-title":"Prevalence and outcomes of anemia and hematinic deficiencies in patients with chronic heart failure","volume":"1","author":"Cleland","year":"2016","journal-title":"JAMA Cardiol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1056\/NEJMoa2304968","article-title":"Ferric carboxymaltose in heart failure with iron deficiency","volume":"389","author":"Mentz","year":"2023","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1016\/S0140-6736(22)02083-9","article-title":"Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial","volume":"400","author":"Kalra","year":"2022","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1002\/ejhf.510","article-title":"Physicians\u2019 adherence to guideline-recommended medications in heart failure with reduced ejection fraction: data from the QUALIFY global survey","volume":"18","author":"Komajda","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"B11","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s40266-026-01302-z","article-title":"Guideline-Directed heart failure pharmacotherapy in adults aged \u226575 years: evidence gaps, tolerability, and implications for clinical practice","volume":"43","author":"Esser","year":"2026","journal-title":"Drugs Aging"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"von Elm","year":"2007","journal-title":"Lancet"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e1001885","DOI":"10.1371\/journal.pmed.1001885","article-title":"The REporting of studies conducted using observational routinely-collected health data (RECORD) statement","volume":"12","author":"Benchimol","year":"2015","journal-title":"PLoS Med"},{"key":"B14","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1001\/jama.1963.03060120024016","article-title":"Studies of illness in the aged: the index of ADL","volume":"185","author":"Katz","year":"1963","journal-title":"JAMA"},{"key":"B15","doi-asserted-by":"publisher","first-page":"S59","DOI":"10.1111\/j.1753-4887.1996.tb03793.x","article-title":"Assessing the nutritional status of the elderly: the Mini nutritional assessment","volume":"54","author":"Guigoz","year":"1996","journal-title":"Nutr Rev"},{"key":"B16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0140-6736(20)30748-0","article-title":"Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials","volume":"396","author":"Vaduganathan","year":"2020","journal-title":"Lancet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/0895-4356(95)00048-8","article-title":"A simulation study of the number of events per variable in logistic regression analysis","volume":"48","author":"Peduzzi","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"6681","DOI":"10.3390\/jcm14186681","article-title":"Nurse specialising consultation in heart failure: impact on drug titration and cardiovascular events in patients with heart failure and reduced ejection fraction","volume":"14","author":"Lopez-Aguilera","year":"2025","journal-title":"J Clin Med"},{"key":"B19","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N Engl J Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.bbamcr.2012.01.014","article-title":"Hepcidin and iron homeostasis","volume":"1823","author":"Ganz","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"B21","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1161\/CIRCULATIONAHA.114.010637","article-title":"Phenomapping for novel classification of heart failure with preserved ejection fraction","volume":"131","author":"Shah","year":"2015","journal-title":"Circulation"},{"key":"B22","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1161\/CIRCULATIONAHA.118.030099","article-title":"Anemia and iron deficiency in heart failure: current concepts and emerging therapies","volume":"138","author":"Anand","year":"2018","journal-title":"Circulation"},{"key":"B23","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 Focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur Heart J"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1942320\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T10:15:54Z","timestamp":1788257754000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2026.1942320\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,1]]},"references-count":23,"alternative-id":["10.3389\/fcvm.2026.1942320"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2026.1942320","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,1]]},"article-number":"1942320"}}